SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-19-015076
Filing Date
2019-12-13
Accepted
2019-12-13 16:12:08
Documents
1
Period of Report
2019-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157627151073429.html 4  
1 FORM 4 wf-form4_157627151073429.xml 4 22265
  Complete submission text file 0001628280-19-015076.txt   23896
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 404 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address
Maslowski John Michael (Reporting) CIK: 0001608774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 191284737